Former Names B6.Cg-T(12;16)1Cje (Changed: 11-JAN-10 ) Type Chromosome Aberration; Translocation; Additional information on Mice with Chromosomal Aberrations. Type Congenic; Mutant Strain; Additional information on Genetically Engineered and Mutant Mice. Visit our online Nomenclature tutorial. Additional information on Congenic nomenclature. Species laboratory mouse
Strains carrying Ts(16C-tel)1Cje allele
004861 B6EiC3Sn-Ts(16C-tel)1Cje/DnJView Strains carrying Ts(16C-tel)1Cje (1 strain)
Currently there is no phenotype information for this strain.
|Gene Symbol and Name||T(12;16)1Cje, reciprocal translocation, Chr 12 and 16, Epstein 1|
|Allele Name||trisomy, (16C-tel), 1 Charles J Epstein|
|Common Name(s)||Ts(1216)1Cje; Ts108Cje; Ts1Cje; partial trisomy 16;|
|Strain of Origin||C57BL/6J x (Rb(11.16)2H x Rb(16.17)32Lub)F1|
|ES Cell Line Name||CB1-4|
|ES Cell Line Strain||C57BL/6J x (Rb(11.16)2H x Rb(16.17)32Lub)F1|
|Gene Symbol and Name||Ts(16C-tel)1Cje, trisomy, (16C-tel), 1 Charles J Epstein|
|Gene Common Name(s)||Ts(1216)1Cje; Ts108Cje; Ts1Cje; partial trisomy 16; trisomy,Chr 12 translocation to Chr 16, Charles J Epstein;|
Sago H; Carlson EJ; Smith DJ; Kilbridge J; Rubin EM; Mobley WC; Epstein CJ; Huang TT. 1998. Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities. Proc Natl Acad Sci U S A 95(11):6256-61. [PubMed: 9600952] [MGI Ref ID J:47907]
Sago H; Carlson EJ; Smith DJ; Rubin EM; Crnic LS; Huang TT; Epstein CJ. 2000. Genetic dissection of region associated with behavioral abnormalities in mouse models for Down syndrome. Pediatr Res 48(5):606-13. [PubMed: 11044479] [MGI Ref ID J:86822]
Huang TT; Yasunami M; Carlson EJ; Gillespie AM; Reaume AG; Hoffman EK ; Chan PH ; Scott RW ; Epstein CJ. 1997. Superoxide-mediated cytotoxicity in superoxide dismutase-deficient fetal fibroblasts. Arch Biochem Biophys 344(2):424-32. [PubMed: 9264557] [MGI Ref ID J:42265]Ts(16C-tel)1Cje related
Adorno M; Sikandar S; Mitra SS; Kuo A; Nicolis Di Robilant B; Haro-Acosta V; Ouadah Y; Quarta M; Rodriguez J; Qian D; Reddy VM; Cheshier S; Garner CC; Clarke MF. 2013. Usp16 contributes to somatic stem-cell defects in Down's syndrome. Nature 501(7467):380-4. [PubMed: 24025767] [MGI Ref ID J:206099]
Alford KA; Slender A; Vanes L; Li Z; Fisher EM; Nizetic D; Orkin SH; Roberts I; Tybulewicz VL. 2010. Perturbed hematopoiesis in the Tc1 mouse model of Down syndrome. Blood 115(14):2928-37. [PubMed: 20154221] [MGI Ref ID J:160790]
Alves-Sampaio A; Troca-Marin JA; Montesinos ML. 2010. NMDA-mediated regulation of DSCAM dendritic local translation is lost in a mouse model of Down's syndrome. J Neurosci 30(40):13537-48. [PubMed: 20926679] [MGI Ref ID J:165095]
Amano K; Sago H; Uchikawa C; Suzuki T; Kotliarova SE; Nukina N; Epstein CJ; Yamakawa K. 2004. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome. Hum Mol Genet 13(13):1333-40. [PubMed: 15138197] [MGI Ref ID J:91249]
Belichenko PV; Kleschevnikov AM; Salehi A; Epstein CJ; Mobley WC. 2007. Synaptic and cognitive abnormalities in mouse models of Down syndrome: exploring genotype-phenotype relationships. J Comp Neurol 504(4):329-45. [PubMed: 17663443] [MGI Ref ID J:132525]
Bhutta MF; Cheeseman MT; Herault Y; Yu YE; Brown SD. 2013. Surveying the Down syndrome mouse model resource identifies critical regions responsible for chronic otitis media. Mamm Genome :. [PubMed: 24068166] [MGI Ref ID J:201811]
Canzonetta C; Mulligan C; Deutsch S; Ruf S; O'Doherty A; Lyle R; Borel C; Lin-Marq N; Delom F; Groet J; Schnappauf F; De Vita S; Averill S; Priestley JV; Martin JE; Shipley J; Denyer G; Epstein CJ; Fillat C; Estivill X; Tybulewicz VL; Fisher EM; Antonarakis SE; Nizetic D. 2008. DYRK1A-dosage imbalance perturbs NRSF/REST levels, deregulating pluripotency and embryonic stem cell fate in Down syndrome. Am J Hum Genet 83(3):388-400. [PubMed: 18771760] [MGI Ref ID J:140118]
Carmichael CL; Majewski IJ; Alexander WS; Metcalf D; Hilton DJ; Hewitt CA; Scott HS. 2009. Hematopoietic defects in the Ts1Cje mouse model of Down syndrome. Blood 113(9):1929-37. [PubMed: 19109561] [MGI Ref ID J:145995]
Colas D; Valletta JS; Takimoto-Kimura R; Nishino S; Fujiki N; Mobley WC; Mignot E. 2008. Sleep and EEG features in genetic models of Down syndrome. Neurobiol Dis 30(1):1-7. [PubMed: 18282758] [MGI Ref ID J:136520]
Duchon A; Raveau M; Chevalier C; Nalesso V; Sharp AJ; Herault Y. 2011. Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling down syndrome. Mamm Genome 22(11-12):674-84. [PubMed: 21953411] [MGI Ref ID J:178872]
Hewitt CA; Ling KH; Merson TD; Simpson KM; Ritchie ME; King SL; Pritchard MA; Smyth GK; Thomas T; Scott HS; Voss AK. 2010. Gene network disruptions and neurogenesis defects in the adult Ts1Cje mouse model of Down syndrome. PLoS One 5(7):e11561. [PubMed: 20661276] [MGI Ref ID J:163093]
Huang TT; Yasunami M; Carlson EJ; Gillespie AM; Reaume AG; Hoffman EK ; Chan PH ; Scott RW ; Epstein CJ. 1997. Superoxide-mediated cytotoxicity in superoxide dismutase-deficient fetal fibroblasts. Arch Biochem Biophys 344(2):424-32. [PubMed: 9264557] [MGI Ref ID J:42265]
Ishihara K; Amano K; Takaki E; Ebrahim AS; Shimohata A; Shibazaki N; Inoue I; Takaki M; Ueda Y; Sago H; Epstein CJ; Yamakawa K. 2009. Increased lipid peroxidation in Down's syndrome mouse models. J Neurochem 110(6):1965-76. [PubMed: 19645748] [MGI Ref ID J:152486]
Ishihara K; Amano K; Takaki E; Shimohata A; Sago H; Epstein CJ; Yamakawa K. 2010. Enlarged brain ventricles and impaired neurogenesis in the Ts1Cje and Ts2Cje mouse models of Down syndrome. Cereb Cortex 20(5):1131-43. [PubMed: 19710359] [MGI Ref ID J:174165]
Klusmann JH; Godinho FJ; Heitmann K; Maroz A; Koch ML; Reinhardt D; Orkin SH; Li Z. 2010. Developmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis. Genes Dev 24(15):1659-72. [PubMed: 20679399] [MGI Ref ID J:163249]
Laffaire J; Rivals I; Dauphinot L; Pasteau F; Wehrle R; Larrat B; Vitalis T; Moldrich RX; Rossier J; Sinkus R; Herault Y; Dusart I; Potier MC. 2009. Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development. BMC Genomics 10:138. [PubMed: 19331679] [MGI Ref ID J:148509]
Levine S; Saltzman A; Levy E; Ginsberg SD. 2009. Systemic pathology in aged mouse models of Down's syndrome and Alzheimer's disease. Exp Mol Pathol 86(1):18-22. [PubMed: 19041304] [MGI Ref ID J:174270]
Mouton-Liger F; Thomas S; Rattenbach R; Magnol L; Larigaldie V; Ledru A; Herault Y; Verney C; Creau N. 2011. PCP4 (PEP19) overexpression induces premature neuronal differentiation associated with Ca(2+) /Calmodulin-Dependent kinase II-delta activation in mouse models of down syndrome. J Comp Neurol 519(14):2779-802. [PubMed: 21491429] [MGI Ref ID J:174150]
Olson LE; Roper RJ; Baxter LL; Carlson EJ; Epstein CJ; Reeves RH. 2004. Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn exhibit variable severity of cerebellar phenotypes. Dev Dyn 230(3):581-9. [PubMed: 15188443] [MGI Ref ID J:91221]
Potier MC; Rivals I; Mercier G; Ettwiller L; Moldrich RX; Laffaire J; Personnaz L; Rossier J; Dauphinot L. 2006. Transcriptional disruptions in Down syndrome: a case study in the Ts1Cje mouse cerebellum during post-natal development. J Neurochem 97 Suppl 1:104-9. [PubMed: 16635258] [MGI Ref ID J:144411]
Richtsmeier JT; Zumwalt A; Carlson EJ; Epstein CJ; Reeves RH. 2002. Craniofacial phenotypes in segmentally trisomic mouse models for Down syndrome. Am J Med Genet 107(4):317-24. [PubMed: 11840489] [MGI Ref ID J:73800]
Salehi A; Delcroix JD; Belichenko PV; Zhan K; Wu C; Valletta JS; Takimoto-Kimura R; Kleschevnikov AM; Sambamurti K; Chung PP; Xia W; Villar A; Campbell WA; Kulnane LS; Nixon RA; Lamb BT; Epstein CJ; Stokin GB; Goldstein LS; Mobley WC. 2006. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron 51(1):29-42. [PubMed: 16815330] [MGI Ref ID J:122937]
Salehi A; Faizi M; Colas D; Valletta J; Laguna J; Takimoto-Kimura R; Kleschevnikov A; Wagner SL; Aisen P; Shamloo M; Mobley WC. 2009. Restoration of norepinephrine-modulated contextual memory in a mouse model of Down syndrome. Sci Transl Med 1(7):7ra17. [PubMed: 20368182] [MGI Ref ID J:167886]
Shukkur EA; Shimohata A; Akagi T; Yu W; Yamaguchi M; Murayama M; Chui D; Takeuchi T; Amano K; Subramhanya KH; Hashikawa T; Sago H; Epstein CJ; Takashima A; Yamakawa K. 2006. Mitochondrial dysfunction and tau hyperphosphorylation in Ts1Cje, a mouse model for Down syndrome. Hum Mol Genet 15(18):2752-62. [PubMed: 16891409] [MGI Ref ID J:114926]
Siarey RJ; Villar AJ; Epstein CJ; Galdzicki Z. 2005. Abnormal synaptic plasticity in the Ts1Cje segmental trisomy 16 mouse model of Down syndrome. Neuropharmacology 49(1):122-8. [PubMed: 15992587] [MGI Ref ID J:106375]
Siddiqui A; Lacroix T; Stasko MR; Scott-McKean JJ; Costa AC; Gardiner KJ. 2008. Molecular responses of the Ts65Dn and Ts1Cje mouse models of Down syndrome to MK-801. Genes Brain Behav 7(7):810-20. [PubMed: 19125866] [MGI Ref ID J:151137]
Vialard F; Toyama K; Vernoux S; Carlson EJ; Epstein CJ; Sinet PM; Rahmani Z. 2000. Overexpression of mSim2 gene in the zona limitans of the diencephalon of segmental trisomy 16 Ts1Cje fetuses, a mouse model for trisomy 21: a novel whole-mount based RNA hybridization study. Brain Res Dev Brain Res 121(1):73-8. [PubMed: 10837894] [MGI Ref ID J:62599]
Villar AJ; Belichenko PV; Gillespie AM; Kozy HM; Mobley WC; Epstein CJ. 2005. Identification and characterization of a new Down syndrome model, Ts[Rb(12.1716)]2Cje, resulting from a spontaneous Robertsonian fusion between T(171)65Dn and mouse chromosome 12. Mamm Genome 16(2):79-90. [PubMed: 15859352] [MGI Ref ID J:96650]
Zhang L; Fu D; Belichenko PV; Liu C; Kleschevnikov AM; Pao A; Liang P; Clapcote SJ; Mobley WC; Yu YE. 2012. Genetic analysis of Down syndrome facilitated by mouse chromosome engineering. Bioeng Bugs 3(1):8-12. [PubMed: 22126738] [MGI Ref ID J:196862]
Animal Health ReportsProduction of mice from cryopreserved embryos or sperm occurs in a maximum barrier room, G200.
|Pricing for USA, Canada and Mexico shipping destinations|
Cryopreserved Mice - Ready for Recovery
Price (US dollars $) Cryorecovery* $2525.00
At least two mice that carry the mutation (if it is a mutant strain) will be provided. Their genotypes may not reflect those discussed in the strain description. Please inquire for possible genotypes and see additional details below.
Cryorecovery - Standard.
Progeny testing is not required.
The average number of mice provided from recovery of our cryopreserved strains is 10. The total number of animals provided, their gender and genotype will vary. We will fulfill your order by providing at least two pair of mice, at least one animal of each pair carrying the mutation of interest. Please inquire if larger numbers of animals with specific genotype and genders are needed. Animals typically ship between 10 and 14 weeks from the date of your order. If a second cryorecovery is needed in order to provide the minimum number of animals, animals will ship within 25 weeks. IMPORTANT NOTE: The genotypes of animals provided may not reflect the mating scheme utilized by The Jackson Laboratory prior to cryopreservation, or that discussed in the strain description. Please inquire about possible genotypes which will be recovered for this specific strain. The Jackson Laboratory cannot guarantee the reproductive success of mice shipped to your facility. If the mice are lost after the first three days (post-arrival) or do not produce progeny at your facility, a new order and fee will be necessary.
Cryorecovery to establish a Dedicated Supply for greater quantities of mice. Mice recovered can be used to establish a dedicated colony to contractually supply you mice according to your requirements. Price by quotation. For more information on Dedicated Supply, please contact JAX® Services, Tel: 1-800-422-6423 (from U.S.A., Canada or Puerto Rico only) or 1-207-288-5845 (from any location).
|Pricing for International shipping destinations|
Cryopreserved Mice - Ready for Recovery
Price (US dollars $) Cryorecovery* $3283.00
Cryorecovery - Standard.
Progeny testing is not required.
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of mice, products or services, JACKSON will, at its option, provide credit or replacement for the mice or product received or the services provided.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS or services from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE and PRODUCTS are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or services. In addition, special terms and conditions of sale of certain MICE, PRODUCTS or services may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and services by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or services by JACKSON.